55 East Monroe Street
Suite 3300
Chicago, Illinois 60603-5792

Novartis Pays $422.5 Million in Settlement

September 30, 2010
New York Times

The Swiss drug giant Novartis has agreed to pay $422.5 million to settle criminal and civil investigations into the marketing of the antiseizure medicine Trileptal and five other drugs, officials said on Thursday.

The action, including a guilty plea to a misdemeanor and a $185 million criminal fine and forfeiture by Novartis Pharmaceuticals, its United States subsidiary, was announced by the United States attorney in Philadelphia, which has specialized in health care fraud. This is the latest in a series of crackdowns by federal prosecutors and states that have been investigating pharmaceutical companies for illegally promoting drugs for uses not authorized by the Food and Drug Administration. To read the complete article click here.

Attorneys at law

 

resources

False claims act basics

Newsroom

Our successes

Our website uses cookies to improve your experience. By continuing to use this website, you are agreeing to our Cookie Policy.